DOI:
10.1039/D3SC02101G
(Edge Article)
Chem. Sci., 2023,
14, 7537-7544
Enantioselective isothiourea-catalysed reversible Michael addition of aryl esters to 2-benzylidene malononitriles†
Received
24th April 2023
, Accepted 31st May 2023
First published on 2nd June 2023
1. Introduction
Over the last decade, methods for the generation and controlled reactivity of C(1)-ammonium enolates have significantly expanded, with the use of isothioureas alongside cinchona alkaloids pivotal in these advances.1 In recent work, the use of electron-deficient aryl esters as C(1)-ammonium enolate precursors in conjunction with isothiourea catalysts has been developed to broaden the electrophiles traditionally compatible with these intermediates (Scheme 1A).2 The ability of the aryl ester to acylate the Lewis basic isothiourea, liberating the corresponding aryloxide, that can subsequently act as a nucleophile to turn over the Lewis base catalyst after a constructive enantioselective reaction is key to this strategy.3 In these processes the aryloxide is required to fulfil the role of a Brønsted base to generate the C(1)-ammonium enolate as well as a Brønsted acid to protonate the post reaction acyl-ammonium species. The amphoteric aryloxide must therefore possess a delicate balance of pKa, nucleophilicity, and nucleofugality for a reaction to be successful. This approach has allowed a range of enantioselective processes to be developed, ranging from [2,3]-sigmatropic rearrangements2a–d to Michael additions,2e as well as dual catalytic methods that involve transition metal2f–m or Brønsted acid co-catalysts.2n As a representative example of this approach, in previous work we demonstrated the enantioselective base-free isothiourea-catalysed Michael addition of aryl ester pronucleophiles to vinyl bis-sulfones, generating α-functionalised products containing two contiguous tertiary stereogenic centres in excellent yield and stereoselectivity (all ≥99:1 er, Scheme 1A).2e The stereoselectivity observed in these processes using C(1)-ammonium enolates is usually considered to rely upon irreversible nucleophilic addition under kinetic control of the reaction, with energy differences between diastereoisomeric transition states translating to stereoisomeric product ratios. In certain circumstances, post reaction equilibration at an acidic position within the product can result in epimerisation, as for example has been observed at the C(3)-position of β-lactones (Scheme 1B).4 To the best of our knowledge, stereoselectivity that occurs in a reaction process that involves reversible addition of a C(1)-ammonium enolate to an electrophile generated using isothioureas has not been demonstrated to date. In this manuscript, the expansion of the scope of the base-free enantioselective Michael addition of aryl ester pronucleophiles to include 2-benzylidene malononitrile electrophiles is reported (Scheme 1C). Significantly, judicious choice of aryl ester, solvent, and isothiourea proved crucial for optimal yield and stereoselectivity. Mechanistic investigation demonstrated the ability of both the aryloxide and the isothiourea catalyst to promote retro-Michael addition, a process previously unknown for isothiourea-catalysed Michael additions. In some cases, the reversibility of the Michael addition was harnessed alongside a crystallisation-induced diastereomer transformation (CIDT), giving products with enhanced diastereoselectivity (up to 95:5 dr) and with excellent enantioselectivity (up to 99:1 er).
|
| Scheme 1 Examples of C(1)-ammonium enolate reactivity in isothiourea catalysis. | |
2. Results and discussion
2.1 Initial reactivity, observations and recognition of a reversible Michael addition process
Initial investigations began with the reaction of p-nitrophenyl (PNP) ester 1 with 2-benzylidene malononitrile 2 and (R)-BTM 3 (5 mol%) in CH2Cl2. The desired Michael addition product was formed in 58% yield as an equal (49:51 dr) mixture of diastereoisomers, giving anti-4 with moderate enantioselectivity (79:21 er) and syn-5 with high enantioselectivity (93:7 er) (Scheme 2A). The absolute (2R,3R)-configuration within syn-5 was unambiguously established by X-ray analysis.5 Initially hypothesising that the difference in enantioselectivity between the diastereoisomeric products may be due to selective in situ epimerisation, the separable products anti-4 (77:23 er, >95:5 dr) and syn-5 (95:5 er, >95:5 dr) were treated with both (R)-BTM and tetrabutylammonium p-nitrophenoxide (Scheme 2B). Interestingly, treatment of both anti-4 and syn-5 with (R)-BTM returned significant equimolar quantities (23% and 49% respectively) of catalysis substrates PNP ester 1 and 2-benzylidene malononitrile 2 (condition A), consistent with retro-Michael addition under these conditions. To date, isothiourea-promoted retro-Michael additions has not been observed, although a related retro-Michael addition to generate benzylidene malononitriles has been reported by Kanger.6 Treatment of both anti-4 and syn-5 with tetrabutylammonium p-nitrophenoxide also promoted retro-Michael addition, although to a significantly reduced extent, giving 10% and 3% of PNP ester 1 and 2-benzylidene malononitrile 2 respectively (conditions B). Consistent with our hypothesis, p-nitrophenoxide led to epimerisation at C(2) of syn-5 but not anti-4. Importantly, HPLC analysis showed that epimerisation of (2R,3R)-syn-5 at C(2) produced (2S,3R)-anti-4 that is the enantiomer of (2R,3S)-anti-4 arising from the (R)-BTM-catalysed reaction. This is consistent with epimerisation of syn-5 contributing to the reduced enantioselectivity observed for anti-4 in Scheme 2A.
|
| Scheme 2 (A) Initial reactivity and (B) evidence of retro-Michael addition and epimerisation. All ers determined by HPLC analysis on a chiral stationary phase. [a] er represents (2R,3S):(2S,3R). [b] er represents (2R,3R):(2S,3S). | |
2.2 Importance of aryloxide
Based upon these results, further work considered changing the basicity of the in situ generated aryloxide through variation of the aryl ester. It was considered this approach could mitigate both epimerisation and retro-Michael addition both of which are expected to proceed via deprotonation at C(2)- and C(4)-respectively within the product (Table 1). While our previous studies have often shown that p-nitrophenyl esters deliver optimal yields and stereoselectivities,2a–c,2p–r,7 Snaddon and Waser have both utilised pentafluorophenyl esters in dual isothiourea/palladium-catalysed α-allylations2f–j and α-chlorinations8 respectively. The steric and electronic effects of the aryloxide leaving group were therefore examined to gain insight into their effects in the model reaction process. The ester of 3,5-bis(trifluoromethyl)phenol 6 (bis-CF3, pKa 8.26;9 compared with p-nitrophenol, pKa 7.16 (ref. 10)) gave a 48:52 mixture of diastereoisomers 10:11 with improved enantioselectivity for both diastereoisomers (entry 2, 87:13 eranti, 97:3 ersyn). The ester of 2,4,6-trichlorophenol (TCP, pKa 5.99)117 was completely unreactive presumably due to steric hindrance (entry 3). Pleasingly, using the esters of 2,3,4,5,6-pentafluorophenol (PFP, pKa 5.53)118 (entry 4) and 2,3,5,6-tetrafluorophenol (TeFP, pKa 6.00)119 (entry 5) gave the corresponding products 12:13 and 14:15 with improved diastereo- and enantioselectivity. The TeFP esters were chosen for further optimisation and control studies.
Table 1 Variation of aryl estera
Isolated enantioenriched TeFP products anti-14 (>95:5 dr, 98:2 er) and syn-15 (>95:5 dr, 94:6 er) were treated analogously with (R)-BTM and NBu4OTeFP (Scheme 3A). Treatment with (R)-BTM resulted in increased retro-Michael addition compared to PNP products anti-4 and syn-5 (46% and 56% vs. 23% and 49%). Moreover, treatment of syn-15 with 2,3,5,6-tetrafluorophenoxide showed four times less epimerisation than syn-5 with p-nitrophenoxide (1% vs. 4%), consistent with our hypothesis that the basicity of aryloxide was important for both yield and stereoselectivity. To further probe the selectivity observed in the TeFP ester series, the evolution of product diastereoselectivity with time under these reaction conditions was monitored by 1H NMR spectroscopic analysis in CD2Cl2 (Scheme 3B). At low conversions and short reaction times the dr of anti-14:syn-15 was moderate (55:45 dr) but increased with time (anti-14:syn-15 65:35 dr after 24 hours), consistent with the retro-Michael control studies. Interestingly, attempted separation of the diastereoisomeric products by chromatographic purification on silica often led to significant variation in isolated product er (ranging from 92:8 to 99:1 er). Extensive studies indicated this to be due to the phenomenon of self-disproportionation of enantiomers (SDE)12 with the er of a given sample not representative of the entire reaction mixture. To ensure that spurious product enantiomeric ratios were not reported during further optimisation of reaction conditions, the products were therefore purposefully isolated as a mixture of diastereoisomers.
|
| Scheme 3 Probing retro-Michael addition and epimerisation in TeFP esters. All ers determined by HPLC analysis on a chiral stationary phase. [a] er represents (2R,3S):(2S,3R). [b] er represents (2R,3R):(2S,3S). | |
2.3 Reaction optimisation
The reaction conditions were further optimised using TeFP ester 9 (Table 2). Increasing the reaction concentration to 1.0 M led to improved yield (72%) with similar levels of diastereo- and enantiocontrol (entry 1). Doubling the catalyst loading to 10 mol% improved diastereoselectivity (85:15 dr) but reduced enantioselectivity, particularly of syn-15 (83:17 ersyn, entry 2). Attempting to improve conversion, the reaction was carried out at 40 °C (entry 3) but this led to decreased yield and stereoselectivity. Variation of the reaction solvent indicated that in both EtOAc and dimethyl carbonate (DMC) the product anti-14:syn-15 precipitated from the reaction mixture with an accompanied increase in yield (78% and 76%, entries 4 and 5). Precipitation was also observed in Et2O, giving anti-14:syn-15 with improved yield and stereoselectivity (entry 6). Increasing the reaction time in Et2O to 48 h gave anti-14 in quantitative yield (entry 7). Simple filtration of the reaction mixture afforded anti-14 as a single diastereoisomer (>95:5 dr), indicating the feasibility of a CIDT.13 While a range of highly selective CIDT processes have been developed, these processes are generally underutilised as a strategy for enantioselective synthesis.13a When demonstrated, CIDT processes often provide routes to a single product diastereoisomer by crystallisation from an equilibrating mixture of isomers. For example, Johnson and co-workers recently harnessed a doubly stereodivergent CIDT process that involved a chiral bifunctional iminophosphorane catalysed enantioselective conjugate addition process between a nitroalkane and a Michael acceptor. This procedure gave γ-nitro-β-ketoamides containing three contiguous stereogenic centres in excellent yield and stereoselectivity (typically >95:5 dr, >95:5 er) due to catalyst-controlled epimerisation and subsequent CIDT.14 In the case described herein, the diastereoisomeric products interconvert through reversible Michael-addition, and to the best of our knowledge is the first CIDT process of its kind, with precipitation of the product beneficial as it can no longer participate in the retro-Michael addition. Building upon these results, various isothiourea catalysts were next screened to improve product enantioselectivity in this protocol. When (S)-TM 16 was used the reaction rate significantly decreased, giving only 45% yield after 168 h (entry 8). The use of (2S,3R)-HyperBTM 17 allowed the reaction time to be reduced to 24 h whilst maintaining the excellent yield and diastereoselectivity, but with reduced 79:21 er (entry 9). (S)-i-Pr-BTM 18 (ref. 15) gave anti-14 in 99% yield as a single diastereoisomer with excellent 98:2 er, albeit with a reaction time of 96 h (entry 10). Optimal stereocontrol and reduced reaction time was observed using (4bR,11aS)-fused-BTM 19 (ref. 15) for 24 h, giving anti-14 with excellent enantioselectivity (99:1 er) with similarly excellent yield and dr (entry 11). Finally, Et2O could be substituted for the more industrially preferable16 CPME to give the optimised reaction conditions where again a CIDT process was observed. Filtration of the product precipitate directly gave anti-14 in 65% yield, >95:5 dr and 99:1 er, with the filtrate giving a 63:37 mixture of anti-14:syn-15 (both 95:5 er, entry 12). Alternatively, concentration of the reaction mixture, followed by chromatographic purification gave anti-14 with 95:5 dr in 92% isolated yield with 99:1 er (entry 13).
Table 2 Optimisation of reaction conditionsa
2.4 Scope and limitations of the reversible Michael addition
With the optimised reaction conditions established the scope and limitations of the Michael addition process was investigated using (4bR,11aS)-fused-BTM 19 (Scheme 4). The relative and absolute configuration of (2R,3S)-14 was confirmed by single crystal X-ray crystallography, with the configuration within all other products assigned by analogy.17 A variety of TeFP esters were synthesised from the corresponding α-aryl, α-alkenyl and α-alkyl substituted carboxylic acids and tested in this protocol. Electron-donating 4-MeOC6H4 and 4-Me2NC6H4 substituents were well tolerated, giving products 20 and 21 in high yields and with excellent stereoselectivity (78% and 69% respectively, both 99:1 er). CIDT of 21 led to moderate isolated yield by direct filtration (19%, >95:5 dr, 99:1 er), or alternatively concentration of the reaction mixture followed by purification led to improved diastereoselectivity (90:10 dr) against that of 20 (80:20 dr). 3-MeC6H4 substitution gave 22 in good yield and excellent stereoselectivity (65%, 90:10 dr, 99:1 er) without a CIDT process in operation. Ortho-substitution was also tolerated, giving product 23 but with reduced yield and enantioselectivity (41%, 91:9 er, 76:24 dr). Extension to incorporate 3-thiophenyl and prop-1-enyl substituents gave the corresponding products 24 and 25 in good yields (76% and 52%) with excellent enantioselectivity (97:3 and 99:1 er). Consistent with our previous studies,2e,n,2p a notable limitation of this process showed that an α-alkyl substituent was not tolerated, with Me-substituted TeFP ester 33 proving unreactive and returning only starting material. The scope and limitations with respect to the vinyl dinitrile Michael acceptors was next investigated, with a small selection synthesised by Knoevenagel condensation of malononitrile with the requisite aldehyde. Electron-withdrawing 4-F3CC6H4 and 4-O2NC6H4 substituents gave products 26 and 27 respectively in high yields (69% and 81%) with excellent enantioselectivity (98:2 and 99:1 er). Halogen containing 4-FC6H4 and 4-ClC6H4 substituents were also well tolerated giving products 28 and 29 in good yields (65% and 63%), again with excellent enantioselectivity (both 99:1 er). CIDT of product 28 allowed its isolation in good yield by direct filtration (57%, >95:5 dr, 99:1 er), while alternatively concentration of the reaction mixture followed by purification still gave 28 produced with excellent diastereoselectivity (92:8 dr). 3-F3CC6H4 substitution gave product 30 in very high yield (86%) with excellent enantioselectivity (97:3 er). 2-F3CC6H4 substitution gave product 31 in reduced 58% yield, presumably due to increased steric hindrance biasing the equilibrium, with the excellent enantioselectivity (99:1 er) maintained. Incorporation of an electron-donating 4-MeOC6H4 substituent led to reduced conversion to product reflecting the assumed reduced electrophilicity of the Michael acceptor containing this conjugating donor substituent, giving product 32 with excellent enantioselectivity (99:1 er) but in low 33% yield. Consistent with this observation, incorporation of the stronger electron-donating 4-Me2NC6H4 substituent within 34 was not tolerated, returning only starting material. Attempted replacement of the β-aryl substituent within either cinnamyl 35 or ethyl 36 substituted vinyl dinitrile Michael acceptors again returned only starting material and so represent limitations of this methodology.
|
| Scheme 4 Scope and limitations. Reactions performed on 0.5 mmol scale. dr determined by 1H NMR analysis of the crude reaction mixture OR after direct filtration. er determined by HPLC analysis on a chiral stationary phase. [a] Combined yield of separable diastereoisomers. [b] Yield of major diastereoisomer. [c] CIDT process in operation; grey highlighted boxes indicate yield, dr and er isolated after filtration. [d] CH2Cl2 was solvent. [e] Combined yield of inseparable diastereoisomers. | |
2.5 Scale-up and derivatisation
The isothiourea-catalysed Michael addition was successfully implemented on gram-scale to give 1.10 g (81%) of anti-14 (Scheme 5). Recrystallisation of the crude reaction mixture allowed a chromatography-free preparation of anti-14 as a single stereoisomer (>95:5 dr, >99:1 er). Anti-14 was then derivatised to allyl amide 37 and methyl ester 38 in good yields (61% and 67%) and as single stereoisomers (>95:5 dr, >99:1 er) despite competing retro-Michael addition being observed in both cases. Interestingly, control studies indicated that the derivatised ester and amide products 37 and 38 were stable to retro-Michael addition.
|
| Scheme 5 Gram-scale catalytic demonstration and product derivatisations. | |
As an alternative derivatisation, desymmetrisation of the geminal dinitriles within 38 by palladium-catalysed hydration gave 39 in excellent yield (90%) with good diastereoselectivity (86:14 dr) and without degradation of enantiopurity (>99:1 er). The (2R,3S,4R) relative and absolute configuration within the major diastereoisomer 39 was proven by X-ray crystallographic analysis.18
2.6 Reversible Michael addition control reaction and proposed mechanism
Further conclusive evidence of the reversible nature of the Michael addition process was sought. Unambiguous demonstration of the feasibility of this process was observed through treatment of racemic Michael addition product anti-14 (>95:5 dr) under the standard reaction conditions using the isothiourea (4bR,11aS)-fused-BTM 19 (5 mol%) in CPME at RT in the presence of 4-MeOC6H4-substituted TeFP ester 40 (Scheme 6A). After 24 hours, 13% of Michael addition product 20 (>95:5 dr, 99:1 er) was isolated, indicating that constructive Michael addition of the dinitrile acceptor arising from retro-Michael addition of product 14 was feasible. Based on previous studies2e and the observations reported herein, a catalytic cycle for this transformation can be proposed (Scheme 6B). (4bR,11aS)-Fused-BTM 19 is reversibly acylated by a TeFP ester to form acyl ammonium ion pair 41. Reversible deprotonation by the aryloxide then generates selectively the (Z)-C(1)-ammonium enolate 42 which is stabilised by a 1,5-O⋯S chalcogen bonding interaction .19–21 Michael addition to vinyl dinitrile generates the acyl ammonium intermediate 43 that is subsequently protonated by the 2,3,5,6-tetrafluorophenol to give acyl ammonium ion pair 44. The aryloxide subsequently effects catalyst turnover to afford product 45 with excellent enantioselectivity, with CIDT leading to enhanced diastereoselectivity in specific examples.
|
| Scheme 6 Proposed catalytic cycle. [a] Yield determined by 1H NMR analysis of the crude reaction mixture using 1,3,5-trimethoxybenzene internal standard. | |
Based on this catalytic cycle and control studies, retro-Michael addition could in principle occur from both the acyl ammonium intermediate 43 and the ester product 45 and we currently cannot distinguish unambiguously between both possibilities. Since our studies have demonstrated that aryloxide turnover to give α,α-difunctionalised ester products is irreversible in the presence of an isothiourea,22 it seems likely that the isothiourea acts as a Brønsted base to promote retro-Michael addition from product 45.
3. Conclusions
In conclusion, the scope and limitations of the base-free enantioselective Michael addition of 2,3,5,6-tetrafluorophenyl esters to 2-benzylidene malononitriles have been demonstrated. Variation of the substitution on both electrophilic and nucleophilic reaction partners was tolerated giving generally good yields and diastereoselectivity with excellent enantioselectivity. Mechanistic investigation determined that retro-Michael addition is promoted by both isothiourea (4bR,11aS)-fused-BTM 19 and nucleofuge 2,3,5,6-tetrafluorophenoxide. In three examples the reversible nature of the Michael addition was exploited to achieve excellent product diastereoselectivity through a novel CIDT. The reaction can be readily carried out upon a gram scale and derivatised to allow access to a variety of stereodefined products. Further applications of the reversible Michael addition process are currently under investigation in this laboratory.
Data availability
The research data supporting this publication can be accessed at: A. J. Nimmo, J. Bitai, C. M. Young, A. M. Z. Slawin, D. B. Cordes and A. D. Smith, Data underpinning: “Enantioselective isothiourea-catalysed reversible Michael addition of aryl esters to 2-benzylidene malononitriles”, University of St Andrews Research Portal, 2023, DOI: http://10.17630/84e083be-87f4-482e-9f60-c9f08eab44cb.
Author contributions
AJN carried out all experimental studies in consultation with JB and CMY. CM carried our preliminary work that led to this project. ADS, AJN and CMY wrote the manuscript. AMZS and DBC carried out single crystal X-ray analysis. All authors agreed on the finalised version of the manuscript.
Conflicts of interest
There are no conflicts to declare.
Acknowledgements
The research leading to these results has received funding from the EaSI-CAT Centre for Doctoral Training (AJN), the University of St Andrews (JB), and the EPSRC (CMY, EP/S019359/1; CM, EP/M508214/1).
References
- For reviews see:
(a) M. J. Gaunt and C. C. C. Johansson, Chem. Rev., 2007, 107, 5596–5605 CrossRef CAS PubMed;
(b) L. C. Morrill and A. D. Smith, Chem. Soc. Rev., 2014, 43, 6214–6226 RSC;
(c) C. McLaughlin and A. D. Smith, Chem.–Eur. J., 2021, 27, 1533–1555 CrossRef CAS PubMed.
-
(a) T. H. West, D. S. Daniels, A. M. Z. Slawin and A. D. Smith, J. Am. Chem. Soc., 2014, 136, 4476–4479 CrossRef CAS PubMed;
(b) S. S. M. Spoehrle, T. H. West, J. E. Taylor, A. M. Z. Slawin and A. D. Smith, J. Am. Chem. Soc., 2017, 139, 11895–11902 CrossRef CAS PubMed;
(c) K. Kasten, A. M. Z. Slawin and A. D. Smith, Org. Lett., 2017, 19, 5182–5185 CrossRef CAS PubMed;
(d) L. Zhang, Z.-J. Zhang, J.-Y. Xiao and J. Song, Org. Lett., 2018, 20, 5519–5522 CrossRef CAS PubMed;
(e) C. McLaughlin, A. M. Z. Slawin and A. D. Smith, Angew. Chem., Int. Ed., 2019, 58, 15111–15119 CrossRef CAS PubMed;
(f) K. J. Schwarz, J. L. Amos, J. C. Klein, D. T. Do and T. N. Snaddon, J. Am. Chem. Soc., 2016, 138, 5214–5217 CrossRef CAS PubMed;
(g) L. Hutchings-Goetz, C. Yang and T. N. Snaddon, ACS Catal., 2018, 8, 10537–10544 CrossRef CAS PubMed;
(h) W. R. Scaggs and T. N. Snaddon, Chem.–Eur. J., 2018, 24, 14378–14381 CrossRef CAS PubMed;
(i) J. W. B. Fyfe, O. M. Kabia, C. M. Pearson and T. N. Snaddon, Tetrahedron, 2018, 74, 5383–5391 CrossRef CAS PubMed;
(j) K. J. Schwarz, C. M. Pearson, G. A. Cintron-Rosado, P. Liu and T. N. Snaddon, Angew. Chem., Int. Ed., 2018, 57, 7800–7803 CrossRef CAS PubMed;
(k) K. J. Schwarz, C. Yang, J. W. B. Fyfe and T. N. Snaddon, Angew. Chem., Int. Ed., 2018, 57, 12102–12105 CrossRef CAS PubMed;
(l) X. Jiang, J. J. Beiger and J. F. Hartwig, J. Am. Chem. Soc., 2017, 139, 87–90 CrossRef CAS PubMed;
(m) J. Bitai, A. M. Z. Slawin, D. B. Cordes and A. D. Smith, Molecules, 2020, 25, 2463 CrossRef CAS PubMed;
(n) F. Zhao, C. Shu, C. M. Young, C. Carpenter-Warren, A. M. Z. Slawin and A. D. Smith, Angew. Chem., Int. Ed., 2021, 60, 11892–11900 CrossRef CAS PubMed;
(o) B. Kim, Y. Kim and S. Y. Lee, J. Am. Chem. Soc., 2021, 143, 73–79 CrossRef CAS PubMed;
(p) J. N. Arokianathar, A. B. Frost, A. M. Z. Slawin, D. Stead and A. D. Smith, ACS Catal., 2018, 8, 1153–1160 CrossRef CAS;
(q) C. McLaughlin, J. Bitai, L. J. Barber, A. M. Z. Slawin and A. D. Smith, Chem. Sci., 2021, 12, 12001–12011 RSC;
(r) J. N. Arokianathar, W. C. Hartley, C. McLaughlin, M. D. Greenhalgh, D. Stead, S. Ng, A. M. Z. Slawin and A. D. Smith, Molecules, 2021, 26, 6333 CrossRef CAS PubMed.
- W. C. Hartley, T. J. C. O'Riordan and A. D. Smith, Synthesis, 2017, 49, 3303–3310 CrossRef CAS.
- Y. Abdelhamid, K. Kasten, J. Dunne, W. C. Hartley, C. M. Young, D. B. Cordes, A. M. Z. Slawin, S. Ng and A. D. Smith, Org. Lett., 2022, 24, 5444–5449 CrossRef CAS PubMed.
- CCDC 2253984 contains the supplementary crystallographic data for (2R,3R)-5.†.
- M. Kaasik, J. Martõnova, K. Erkman, A. Metsala, I. Järving and T. Kanger, Chem. Sci., 2021, 12, 7561–7568 RSC.
-
(a) J. Wu, C. M. Young, A. A. Watts, A. M. Z. Slawin, G. R. Boyce, M. Bühl and A. D. Smith, Org. Lett., 2022, 24, 4040–4045 CrossRef CAS PubMed;
(b) J. E. Lapetaje, C. M. Young, C. Shu and A. D. Smith, Chem. Commun., 2022, 58, 6886–6889 RSC;
(c) J. Bitai, A. J. Nimmo, A. M. Z. Slawin and A. D. Smith, Angew. Chem., Int. Ed., 2022, 61, e202202621 CrossRef CAS PubMed;
(d) C. Shu, H. Liu, A. M. Z. Slawin, C. Carpenter-Warren and A. D. Smith, Chem. Sci., 2020, 11, 241–247 RSC;
(e) A. Matviitsuk, M. D. Greenhalgh, D.-J. B. Antunez, A. M. Z. Slawin and A. D. Smith, Angew. Chem., Int. Ed., 2017, 56, 12282–12287 CrossRef CAS PubMed.
- L. Stockhammer, D. Weinzierl, T. Bögl and M. Waser, Org. Lett., 2021, 23, 6143–6147 CrossRef CAS PubMed.
- A. Kütt, V. Movchun, T. Rodima, T. Dansauer, E. B. Rusanov, I. Leito, I. Kaljurand, J. Koppel, V. Pihl, I. Koppel, G. Ovsjannikov, L. Toom, M. Mishima, M. Medebielle, E. Lork, G.-V. Röschenthaler, I. A. Koppel and A. A. Kolomeitsev, J. Org. Chem., 2008, 73, 2607–2620 CrossRef PubMed.
- S. Espinosa, E. Bosch and M. Rosés, J. Chromatogr. A, 2002, 964, 55–66 CrossRef CAS PubMed.
- J. Han and F. M. Tao, J. Phys. Chem. A, 2006, 110, 257–263 CrossRef CAS PubMed.
-
(a) J. Han, O. Kitagawa, A. Wzorek, K. D. Klika and V. A. Soloshonok, Chem. Sci., 2018, 9, 1718–1739 RSC;
(b) V. A. Soloshonok, C. Roussel, O. Kitagawa and A. E. Sorochinsky, Chem. Soc. Rev., 2012, 41, 4180–4188 RSC.
-
(a) A. Kolarovič and P. Jakubec, Adv. Synth. Catal., 2021, 363, 4110–4158 CrossRef;
(b) K. M. J. Brands and A. J. Davies, Chem. Rev., 2006, 106, 2711–2733 CrossRef CAS PubMed.
- P. de Jesús Cruz, W. R. Cassels, C.-H. Chen and J. S. Johnson, Science, 2022, 376, 1224–1230 CrossRef PubMed.
- I. Shiina, K. Nakata, K. Ono, Y. Onda and M. Itagaki, J. Am. Chem. Soc., 2010, 132, 11629–11641 CrossRef CAS PubMed.
- D. Prat, A. Wells, J. Hayler, H. Sneddon, C. R. McElroy, S. Abou-Shehada and P. J. Dunn, Green Chem., 2016, 18, 288–296 RSC.
- CCDC 2253985 contains the supplementary crystallographic data for (2R,3S)-14.†.
- CCDC 2253986 contains the supplementary crystallographic data for (2R,3S,4R)-39.†.
- For an early theoretical investigation of chalcogen bonding, see:
(a) C. Bleiholder, R. Gleiter, D. B. Werz and H. Köppel, Inorg. Chem., 2007, 46, 2249–2260 CrossRef CAS PubMed . For a recent review, see:;
(b) R. Gleiter, G. Haberhauer, D. B. Werz, F. Rominger and C. Bleiholder, Chem. Rev., 2018, 118, 2010–2041 CrossRef CAS PubMed . For a recent perspective see:;
(c) S. Kolb, G. A. Oliver and D. B. Werz, Angew. Chem., Int. Ed., 2020, 50, 22306–22310 CrossRef PubMed . For a discussion on the origin of chalcogen-bonding interactions:;
(d) D. J. Pascoe, K. B. Ling and S. L. Cockroft, J. Am. Chem. Soc., 2017, 139, 15160–15167 CrossRef CAS PubMed.
- For selected examples of chalcogen bonding catalysis see:
(a) S. Benz, J. López-Andarias, J. Mareda, N. Sakai and S. Matile, Angew. Chem., Int. Ed., 2017, 56, 812–815 CrossRef CAS PubMed;
(b) P. Wonner, L. Vogel, M. Düser, L. Gomes, F. Kneip, B. Mallick, D. B. Werz and S. M. Huber, Angew. Chem., Int. Ed., 2017, 56, 12009–12012 CrossRef CAS PubMed;
(c) P. Wonner, L. Vogel, F. Kniep and S. M. Huber, Chem.–Eur. J., 2017, 23, 16972–16975 CrossRef CAS PubMed;
(d) P. Wonner, A. Dreger, E. Engelage and S. M. Huber, Angew. Chem., Int. Ed., 2019, 58, 16923–16927 CrossRef CAS PubMed;
(e) W. Wang, H. Zhu, S. Liu, Z. Zhao, L. Zhang, J. Hao and Y. Wang, J. Am. Chem. Soc., 2019, 141, 9175–9179 CrossRef CAS PubMed;
(f) W. Wang, H. Zhu, L. Feng, Q. Yu, J. Hao, R. Zhu and Y. Wang, J. Am. Chem. Soc., 2020, 142, 3117–3124 CrossRef CAS PubMed.
- For discussions of S⋯O interactions in isothiourea catalysis:
(a) V. B. Birman, X. Li and Z. Han, Org. Lett., 2007, 9, 37–40 CrossRef CAS PubMed;
(b) P. Liu, X. Yang, V. B. Birman and K. N. Houk, Org. Lett., 2012, 14, 3288–3291 CrossRef CAS PubMed;
(c) M. E. Abbasov, B. M. Hudson, D. J. Tantillo and D. Romo, J. Am. Chem. Soc., 2014, 136, 4492–4495 CrossRef CAS PubMed;
(d) E. R. T. Robinson, D. M. Walden, C. Fallan, M. D. Greenhalgh, P. H.-Y. Cheong and A. D. Smith, Chem. Sci., 2016, 7, 6919–6927 RSC;
(e) M. D. Greenhalgh, S. M. Smith, D. M. Walden, J. E. Taylor, Z. Brice, E. R. T. Robinson, C. Fallan, D. B. Cordes, A. M. Z. Slawin, H. C. Richardson, M. A. Grove, P. H.-Y. Cheong and A. D. Smith, Angew. Chem., Int. Ed., 2018, 57, 3200–3206 CrossRef CAS PubMed;
(f) C. M. Young, A. Elmi, D. J. Pascoe, R. K. Morris, C. McLaughlin, A. M. Woods, A. B. Frost, A. de la Houpliere, K. B. Ling, T. K. Smith, A. M. Z. Slawin, P. H. Willoughby, S. L. Cockroft and A. D. Smith, Angew. Chem., Int. Ed., 2020, 59, 3705–3710 CrossRef CAS PubMed ; for use of S⋯O interaction in asymmetric synthesis:;
(g) Y. Nagao, S. Miyamoto, M. Miyamoto, H. Takeshige, K. Hayashi, S. Sano, M. Shiro, K. Yamaguchi and Y. Sei, J. Am. Chem. Soc., 2006, 128, 9722–9729 CrossRef CAS PubMed ; for examples of S⋯O interactions in medicinal chemistry:;
(h) B. R. Beno, K.-S. Yeung, M. D. Bartberger, L. D. Pennington and N. A. Meanwell, J. Med. Chem., 2015, 58, 4383–4438 CrossRef CAS PubMed ; for a discussion on the origin of chalcogen-bonding interactions:;
(i) D. J. Pascoe, K. B. Ling and S. L. Cockroft, J. Am. Chem. Soc., 2017, 139, 15160–15167 CrossRef CAS PubMed.
-
(a) Isothiourea-catalysed transesterification of an analogous Michael addition product derived from a TeFP ester and vinyl bis-sulfone was unsuccessful (see ESI†).;
(b) T. H. West, D. M. Walden, J. E. Taylor, A. C. Bruekner, R. C. Johnston, P. H.-Y. Cheong, G. C. Lloyd-Jones and A. D. Smith, J. Am. Chem. Soc., 2017, 139, 4366–4375 CrossRef CAS PubMed.
|
This journal is © The Royal Society of Chemistry 2023 |
Click here to see how this site uses Cookies. View our privacy policy here.